Current position:Home >Product >
2-(2-BroMo-pyridin-3-yloxy)-3-chloro-quinoxaline, 98+% C13H7BrClN3O, MW: 336.58
2-(2-BroMo-pyridin-3-yloxy)-3-chloro-quinoxaline, 98+% C13H7BrClN3O, MW: 336.58(1065484-71-0)
- Name: 2-(2-BroMo-pyridin-3-yloxy)-3-chloro-quinoxaline, 98+% C13H7BrClN3O, MW: 336.58
- Synonyms:2-bromo-3-(3-chloroquinoxalin-2-yloxy)pyridine;2-(2-Bromo-pyridin-3-yloxy)-3-chloro-quinoxaline;
- Molecular Formula:C13H7BrClN3O
- Molecular Weight:336.57
- CAS Registry Number:1065484-71-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1065484-71-0 2-(2-Bromo-pyridin-3-yloxy)-3-chloro-quinoxaline
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] - Hangzhou Hysen Pharma co.,Ltd.
Other Product
- 1065484-64-1/2-(2-BroMo-pyridin-3-yloxy)-pyrazine, 98+% C9H6BrN3O, MW: 252.07
- 1065484-47-0/2-Chloro-N-(3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-acetamide
- 1065484-51-6/2-Chloro-N-(4'-cyano-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-acetaMide, 98+% C13H15ClN4O, MW: 278.74
- 1065484-81-2/2-(6-Chloro-pyriMidin-4-yloxy)-quinoxaline, 98+% C12H7ClN4O, MW: 258.67
- 1065484-49-2/2-Chloro-N-(3'-cyano-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-acetaMide, 98+% C13H15ClN4O, MW: 278.74
- 1065484-50-5/2-Chloro-N-(3'-cyano-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3-yl)-acetaMide, 98+% C13H15ClN4O, MW: 278.74
- 1065484-82-3/2-(4-Chloro-pyriMidin-2-yloxy)-quinoxaline, 98+% C12H7ClN4O, MW: 258.67
- 1185315-66-5/(3-Chloro-5-trifluoroMethyl-pyridin-2-yl)-piperidin-4-yl-aMine hydrochloride, 98+% C11H14Cl2F3N3, MW: 316.15
- 1065484-73-2/2-(2-BroMo-pyridin-3-yloxy)-benzothiazole, 98+% C12H7BrN2OS, MW: 307.17
- 1065484-40-3/3-(6-BroMo-pyridin-2-yloxyMethyl)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C16H23BrN2O3, MW: 371.28
- 1146080-76-3/2-(2-Chloro-benzoiMidazol-1-yl)-nicotinonitrile, 98+% C13H7ClN4, MW: 254.68
- 1065484-39-0/3-(6-BroMo-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C15H21BrN2O3, MW: 357.25
- 1146080-68-3/2-Chloro-1-(3-nitro-pyridin-2-yl)-1H-benzoiMidazole, 98+% C12H7ClN4O2, MW: 274.67
- 871681-76-4/4-(6-BroMo-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C15H21BrN2O3, MW: 357.25
- 1065484-38-9/3-[(6-BroMo-pyridin-2-ylaMino)-Methyl]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C16H24BrN3O2, MW: 370.29
- 1065484-37-8/4-[(6-BroMo-pyridin-2-ylaMino)-Methyl]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C16H24BrN3O2, MW: 370.29
- 1146080-31-0/2-Chloro-1-(5-nitro-pyridin-2-yl)-1H-benzoiMidazole, 98+%
- 1146080-32-1/3-(6-Chloro-pyridin-3-ylMethyl)-1H-Indole, 98+% C14H11ClN2, MW: 242.71
- 1146080-40-1/3-(6-BroMo-pyridin-2-yl)-1H-indole, 98+% C13H9BrN2, MW: 273.13
- 1065484-71-0/2-(2-BroMo-pyridin-3-yloxy)-3-chloro-quinoxaline, 98+% C13H7BrClN3O, MW: 336.58
- 1065484-79-8/2-(5-ChloroMethyl-pyridin-2-yloxy)-quinoxaline, 98+% C14H10ClN3O, MW: 271.71
- 1065484-83-4/2-(6-BroMo-pyridin-2-yloxy)-quinoxaline, 98+% C13H8BrN3O, MW: 302.13
- 1146079-97-1/2-BroMo-6-(1-phenyl-propoxy)-pyridine, 98+% C14H14BrNO, MW: 292.18
- 16880-60-7/3-Chloro-N-isoquinolin-5-yl-propionaMide, 98+% C12H11ClN2O, MW: 234.69
- 1185311-27-6/1-(1-Thiazol-2-yl-ethyl)-piperazine hydrochloride, 98+% C9H16ClN3S, MW: 233.76
- 939986-53-5/4-(2-Chloro-thiazol-5-ylMethyl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C13H20ClN3O2S, MW: 317.84
- 954228-61-6/3-(4-Methyl-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C16H24N2O3, MW: 292.38
- 1185316-81-7/1-Piperazin-1-yl-2-thiophen-3-yl-ethanone hydrochloride, 98+%
- 944390-87-8/4-(4-Methyl-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester
- 1065484-09-4/4-(3-Cyano-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C16H21N3O3, MW: 303.36